Meng-chao Wu

发表

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

Xiuqing Zhang, L. Tang, Hui Jiang, 2016, Nature Communications.

Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model

D. Xie, Xiao-Fan Wang, Hong-Yang Wang, 2011, Hepatology.

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

Xiuqing Zhang, L. Tang, Hui Jiang, 2016, Nature Communications.

Surgical Experience of Giant Hepatoblastoma Involving the Inferior Vena Cava in Children: Report of 21 Cases of a Single Center

Ai-Jun Li, L. Cui, Wei-ping Zhou, 2016 .

Overexpression Of Hepatocyte Nuclear Factor-1beta Predicting Poor Prognosis Is Associated With Biliary Phenotype In Patients With Hepatocellular Carcinoma

Ying-ying Jing, Yulong Dong, Fei Ye, 2015, Scientific Reports.

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.

W. Cong, Weiping Zhou, Hui Dong, 2013, Journal of hepatology.

Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells

Hong-Yang Wang, D. Cao, Lei Chen, 2022, Acta Pharmacologica Sinica.

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

Xiuqing Zhang, L. Tang, Hui Jiang, 2016, Nature Communications.

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

Tian Yang, Yefa Yang, Ai-Jun Li, 2010, British Journal of Cancer.